We present MINOTAUR, an edge system-on-chip (SoC) for inference and fine-tuning of Transformer models with all memory on the chip. MINOTAUR utilizes a configurable 8-bit posit-based accelerator to ...

In 2024, Paladin generated revenues of $70 million excluding products that Paladin has stopped commercializing or is in the process of discontinuing. "The reunion of Paladin and Knight ...

Knight Therapeutics Inc. GUD-T has signed a deal to buy the assets of Paladin Pharma Inc. as the Canadian drug company looks to build out its domestic business after a strategic push into South ...